Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
08/14/2008
Trade Name:
Zyprexa
Generic or Proper Name (*):
olanzapine
Indications Studied:
schizophrenia; bipolar disorder
Therapeutic Category:
Antipsychotic
Ages Studied:
13-17 years
Study #:
2
Study Type:
Pharmacokinetic
Study Design:
Open label/Population Pharmacokinetic
No Patients:
107
No Centers:
22
No Countries:
2
BPCA(B), PREA(P):
B
Asian:
0
Black:
9
Other:
0
White:
91
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
7
Non-Hispanic/Non Latino:
0
-
-